Project Grant R01AI192662
Award Date 9/5/25
Completion Date 8/31/29
Dollars Obligated $5.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The Project Grant award of $189,376 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) supports research to unravel the interactions between skin microbiota and the immune system that drive early-life commensal tolerance. The research aims to better understand the mechanisms by which conserved microbial signals, specifically those recognized by Toll-like Receptor 2 (TLR2), promote the...
- The University of California, Davis received a $126,738 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) on May 29, 2025. The grant supports research to investigate extramedullary granulopoiesis and immune responses in human skin using a novel skin-on-a-chip model. The project aims to provide mechanistic insight into the migration of hematopoietic stem and progenitor cells into human skin and their role in...
- This Project Grant award of $797,735 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research CFDA program, aims to elucidate the innate and adaptive immune mechanisms governing neonatal immune responses and sterile inflammation in early life. The research project will utilize a novel mouse model of allergen-induced neonatal sterile inflammation to investigate heightened innate and adaptive immune responses in neonates compared to...
- This federal Project Grant award for $243,950.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports a series of research aims to develop prognostic models for predicting the long-term course of atopic dermatitis (persistent disease and comorbidities) in diverse global settings, including cohorts from Uganda, Ecuador, and the United Kingdom....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $401,191 Project Grant to The Johns Hopkins University on June 11, 2025 under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The project aims to characterize the neonatal nasal microbiome following a parent-to-child nasal microbiota transplant, with the goal of developing interventions to prevent life-threatening Staphylococcus aureus infections in neonates. The research focuses on...
- The University of California, San Diego (UCSD) was awarded a $3,194,992.00 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on July 16, 2025, supports research to study the roles and regulation of tissue-resident CD8 T cells during a persistent viral infection. The research aims to investigate the mechanisms that allow immune cells to adapt and maintain a long-term...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $891,678 to the Scripps Research Institute in La Jolla, CA to conduct research on how metabolites from the intestinal microbiota can modulate host immune responses. The researchers will employ chemical biology and proteomics methods to identify specific microbiota-associated bile acid protein targets in mammalian cells...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $769,366 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective from February 1, 2025 to January 31, 2030, aims to decipher the ontogeny of CD4+ resident memory T cells that globally seed the skin and protect against cutaneous leishmaniasis. The...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, awarded a $414,368 Project Grant to the University of California, Davis. The grant supports research to characterize the impact of postnatal early-life exposure to house dust mite and ozone on the lung epigenome and explore the mechanistic link between these changes and alveolar development and airway remodeling. The project aims to leverage collected...
- This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) provides $198,782 to Duke University to develop a platform that leverages 3D human reconstructed epidermis (RHE) cultures to investigate interactions between the skin microbiome and skin cell populations. The goal is to enable the investigation of host-microbe interactions at a large scale by knocking out human genes...